ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PMN ProMIS Neurosciences Inc

1.9997
-0.0002 (-0.01%)
Last Updated: 12:03:41
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,290
Bid Price 1.91
Ask Price 2.10
News (1)
Day High 2.0712

Low
0.95

52 Week Range

High
8.95

Day Low 1.90
Share Name Share Symbol Market Stock Type
ProMIS Neurosciences Inc PMN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0002 -0.01% 1.9997 12:03:41
Open Price Low Price High Price Close Price Previous Close
2.0712 1.90 2.0712 1.9999
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
9 1,290 US$ 2.01 US$ 2,596 - 0.95 - 8.95
Last Trade Type Quantity Price Currency
11:54:44 50 US$ 2.00 USD

ProMIS Neurosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
857.93k 8.58M - 0 -13.21M -1.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ProMIS Neurosciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PMN Message Board. Create One! See More Posts on PMN Message Board See More Message Board Posts

Historical PMN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.062.181.902.004,608-0.0603-2.93%
1 Month2.052.611.632.1816,014-0.0503-2.45%
3 Months2.012.611.462.0617,588-0.0103-0.51%
6 Months1.763.100.951.9931,8280.239713.62%
1 Year6.918.950.954.33109,050-4.91-71.06%
3 Years6.949.800.954.3761,573-4.94-71.19%
5 Years6.949.800.954.3761,573-4.94-71.19%

ProMIS Neurosciences Description

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada.

Your Recent History

Delayed Upgrade Clock